Novel bis-C,N-cyclometalated iridium(III) thiosemicarbazide antitumor complexes: interactions with human serum albumin and DNA, and inhibition of cathepsin B.
about
Influence of substituents on DNA and protein binding of cyclometalated Ir(iii) complexes and anticancer activity.Understanding the interaction of an antitumoral platinum(II) 7-azaindolate complex with proteins and DNA.Organoiridium complexes: anticancer agents and catalystsAntitumor and biological investigation of doubly cyclometalated ruthenium(II) organometallics derived from benzimidazolyl derivatives.Cyclometalated iridium(III)-β-carboline complexes as potent autophagy-inducing agents.On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands.Designing new iridium(iii) arene complexes of naphthoquinone derivatives as anticancer agents: a structure-activity relationship study.Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.Ni(II) Complexes with Schiff Base Ligands: Preparation, Characterization, DNA/Protein Interaction and Cytotoxicity Studies.Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization.The [Mo₆Cl14]2- Cluster is Biologically Secure and Has Anti-Rotavirus Activity In Vitro.DNA/HSA interaction and nuclease activity of an iron(III) amphiphilic sulfonated corrole.
P2860
Q32174625-F0B35474-9DA4-4A92-816B-154EE505AC99Q35222016-0C758F2D-02E1-483C-9D11-03F90F3E2163Q37715044-FCF9CE7B-7A50-4DD1-8261-9012D09EA3E3Q38786564-71523012-7FE4-4CA4-BAB7-6FDBC3C9F771Q39004590-ED19BDFB-3B0C-4860-A220-F95CF2010FA8Q39068148-D3745AE8-F2D6-413A-9FD9-CF9031461A98Q42400560-0C24B361-8565-4CA9-8C15-5042DE09DF2DQ46425575-AD67D2F8-22A9-420F-9C9A-63E101CB6021Q47343997-2496BCD7-E4D8-46AF-88F5-C6A883DAC4A0Q47416474-4D2BDC25-BA60-4F13-8031-9E483F89C07AQ48210595-147ED227-D4B2-4729-8238-5A1A0107DDD4Q50203418-65945C24-77DE-4430-8150-92E247F76AD1Q52962355-EEA3EDA8-FB58-4F28-8DAE-D0F6AD2F2C9C
P2860
Novel bis-C,N-cyclometalated iridium(III) thiosemicarbazide antitumor complexes: interactions with human serum albumin and DNA, and inhibition of cathepsin B.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Novel bis-C,N-cyclometalated i ...... and inhibition of cathepsin B.
@ast
Novel bis-C,N-cyclometalated i ...... and inhibition of cathepsin B.
@en
Novel bis-C,N-cyclometalated i ...... and inhibition of cathepsin B.
@nl
type
label
Novel bis-C,N-cyclometalated i ...... and inhibition of cathepsin B.
@ast
Novel bis-C,N-cyclometalated i ...... and inhibition of cathepsin B.
@en
Novel bis-C,N-cyclometalated i ...... and inhibition of cathepsin B.
@nl
prefLabel
Novel bis-C,N-cyclometalated i ...... and inhibition of cathepsin B.
@ast
Novel bis-C,N-cyclometalated i ...... and inhibition of cathepsin B.
@en
Novel bis-C,N-cyclometalated i ...... and inhibition of cathepsin B.
@nl
P50
P356
P1433
P1476
Novel bis-C,N-cyclometalated i ...... and inhibition of cathepsin B
@en
P2093
Delia Bautista
P304
P356
10.1021/IC302219V
P407
P577
2013-01-09T00:00:00Z